102 related articles for article (PubMed ID: 3043451)
1. In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
Stein J; Strandjord S; Saarinen U; Warkentin P; Gerson S; Lazarus H; Von Hoff D; Coccia P; Cheung NK
Prog Clin Biol Res; 1988; 271():237-48. PubMed ID: 3043451
[No Abstract] [Full Text] [Related]
2. Anti-neuroblastoma monoclonal antibodies which do not bind to bone marrow cells.
Frantz CN; Duerst RE; Ryan DH; Gelsomino NL; Constine LS; Gregory PK
Prog Clin Biol Res; 1985; 175():485-99. PubMed ID: 3887430
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
Cheung IY; Lo Piccolo MS; Collins N; Kushner BH; Cheung NK
Cancer; 2002 Jun; 94(11):3042-8. PubMed ID: 12115395
[TBL] [Abstract][Full Text] [Related]
4. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
Duerst RE; Rose D; Frantz CN
Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
[TBL] [Abstract][Full Text] [Related]
5. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
6. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
7. Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture.
Greenberger JS; Rothstein L; DeFabritiis P; Bregni M; Bast R; Ritz J; Nadler LM; Lipton JM; Sakakeeny MA
Cancer Res; 1985 Feb; 45(2):758-67. PubMed ID: 3967246
[TBL] [Abstract][Full Text] [Related]
8. Depletion of T-lymphocytes in donor marrow with pan-T monoclonal antibodies and complement for prevention of acute graft-versus-host disease: a pilot study on 29 patients.
Herve P
J Natl Cancer Inst; 1986 Jun; 76(6):1311-6. PubMed ID: 3520074
[TBL] [Abstract][Full Text] [Related]
9. Very long delay to engraftment after ABMT in neuroblastoma patients and effect of CD8 monoclonal antibody in vivo therapy.
Favrot MC; Philip T; Combaret V; Biron P; Morisset J; Bernard A
Prog Clin Biol Res; 1988; 271():225-36. PubMed ID: 3043450
[No Abstract] [Full Text] [Related]
10. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
11. Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.
Lopez M; Zucker JM; Urresola R; Douay L; Quintana E; Kemshead J; Gorin NC; Vilcoq JR
Bone Marrow Transplant; 1987 Dec; 2(4):413-9. PubMed ID: 3332188
[TBL] [Abstract][Full Text] [Related]
12. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
13. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.
Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P
J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
[TBL] [Abstract][Full Text] [Related]
15. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
16. [Autologous bone marrow transplantation in the treatment of advanced malignant tumors in children and adolescents].
Brun del Re G; Baumgartner C; Bleher EA; Bucher U; Greiner R; Hirt A; Imbach P; Lüthi A; Odavic R; Wagner HP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):243-8. PubMed ID: 6208111
[No Abstract] [Full Text] [Related]
17. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
18. Depletion of T cells from bone marrow for allogeneic transplantation: method for treatment of bone marrow in bulk.
Trigg ME; Peterson A; Erickson C; Bozdech M; Billing R; Sondel P; Finlay J; Surfus J; Stuiber M; Hong R
Exp Hematol; 1986 Jan; 14(1):21-6. PubMed ID: 3080322
[TBL] [Abstract][Full Text] [Related]
19. The use of immunorosettes for purging of bone marrow in childhood cancer.
Slaper-Cortenbach IC; Wijngaarden-du Bois MJ; Admiraal LG; Tetteroo PA; Figdor CG; van Leeuwen EF
Prog Clin Biol Res; 1990; 333():337-44. PubMed ID: 2308990
[No Abstract] [Full Text] [Related]
20. Bone marrow transplantation (BMT) for advanced neuroblastoma (NBL): a multicenter POG pilot study.
Graham-Pole J; Gee AP; Gross S; Casper J; Graham M; Harvey W; Kapoor N; Koch P; Mendenhall N; Norris D
Prog Clin Biol Res; 1988; 271():215-23. PubMed ID: 3043449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
